Drugs / PF-05297909
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01462851 | Sep 2011 → Feb 2012 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-05297909 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01462851 ↗ |
| Route | Oral | “Single oral (PO) dose” NCT01462851 ↗ |